{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:20Z","timestamp":1784141780767,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,5,26]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Patients with Ebstein\u2019s anomaly of the tricuspid valve (EA) are at risk of tachyarrhythmia, congestive heart failure and sudden cardiac death. We sought to determine the value of cardiovascular magnetic resonance (CMR) for predicting these outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seventy-nine consecutive adult patients (aged 37\u00b115 years) with unrepaired EA underwent CMR and were followed prospectively for a median 3.4 (range 0.4\u201310.9) years for clinical outcomes, namely major adverse cardiovascular events (MACEs: sustained ventricular tachycardia\/heart failure hospital admission\/cardiac transplantation\/death) and first-onset atrial tachyarrhythmia (AT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CMR-derived variables associated with MACE (n=6) were right ventricular (RV) or left ventricular (LV) ejection fraction (EF) (HR 2.06, 95% CI 1.168 to 3.623, p=0.012\u2009and HR 2.35, 95% CI 1.348 to 4.082, p=0.003, respectively), LV stroke volume index (HR 2.82, 95% CI 1.212 to 7.092, p=0.028) and cardiac index (HR 1.71, 95% CI 1.002 to 1.366, p=0.037); all remained significant when tested solely for mortality. History of AT (HR 11.16, 95% CI 1.30 to 95.81, p=0.028) and New York Heart Association class &gt;2 (HR 7.66, 95% CI 1.54 to 38.20, p=0.013) were also associated with MACE; AT preceded all but one MACE, suggesting its potential role as an early marker of adverse outcome (p=0.011).<\/jats:p>\n                  <jats:p>CMR variables associated with first-onset AT (n=17; 21.5%) included RVEF (HR 1.55, 95% CI 1.103 to 2.160, p=0.011), total R\/L volume index (HR 1.18, 95% CI 1.06 to 1.32, p=0.002), RV\/LV end diastolic volume ratio (HR 1.55, 95% CI 1.14 to 2.10, p=0.005) and apical septal leaflet displacement\/total LV septal length (HR 1.03, 95% CI 1.00 to 1.07, p=0.041); the latter two combined enhanced risk prediction (HR 6.12, 95% CI 1.67 to 22.56, p=0.007).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CMR-derived indices carry prognostic information regarding MACE and first-onset AT among adults with unrepaired EA. CMR may be included in the periodic surveillance of these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-311274","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T20:40:48Z","timestamp":1499373648000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Major adverse events and atrial tachycardia in Ebstein\u2019s anomaly predicted by cardiovascular magnetic resonance"],"prefix":"10.1136","volume":"104","author":[{"given":"Riikka","family":"Rydman","sequence":"first","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"Department of Molecular Medicine and Surgery, Section of Clinical Physiology, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Shiina","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"Cardiovascular Centre, St. Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard-Paul","family":"Diller","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"National Heart and Lung Institute, Imperial College, London, England"},{"name":"Department of Cardiovascular Medicine, Division of Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Niwa","sequence":"additional","affiliation":[{"name":"Cardiovascular Centre, St. Luke\u2019s International Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Uemura","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Uebing","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Barbero","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"Citt\u00e0 della Salute e della Scienza Hospital, University of Turin, Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bouzas","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Ernst","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"National Heart and Lung Institute, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wong","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley J","family":"Pennell","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"National Heart and Lung Institute, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"National Heart and Lung Institute, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya V","family":"Babu-Narayan","sequence":"additional","affiliation":[{"name":"NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, England"},{"name":"National Heart and Lung Institute, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"2025092100145609000_104.1.37.1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90516-9"},{"key":"2025092100145609000_104.1.37.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.06.047"},{"key":"2025092100145609000_104.1.37.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01169-3"},{"key":"2025092100145609000_104.1.37.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.03.064"},{"key":"2025092100145609000_104.1.37.5","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200001000-00003"},{"key":"2025092100145609000_104.1.37.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000636"},{"key":"2025092100145609000_104.1.37.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs362"},{"key":"2025092100145609000_104.1.37.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592410"},{"key":"2025092100145609000_104.1.37.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.619338"},{"key":"2025092100145609000_104.1.37.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp586"},{"key":"2025092100145609000_104.1.37.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.10.058"},{"key":"2025092100145609000_104.1.37.12","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-51"},{"key":"2025092100145609000_104.1.37.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-011-9923-1"},{"key":"2025092100145609000_104.1.37.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.08.004"},{"key":"2025092100145609000_104.1.37.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001467"},{"key":"2025092100145609000_104.1.37.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.12.081"},{"key":"2025092100145609000_104.1.37.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.045"},{"key":"2025092100145609000_104.1.37.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl336"},{"key":"2025092100145609000_104.1.37.19","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-14-51"},{"key":"2025092100145609000_104.1.37.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.2.353"},{"key":"2025092100145609000_104.1.37.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.037"},{"key":"2025092100145609000_104.1.37.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.08.018"},{"key":"2025092100145609000_104.1.37.23","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.4.819"},{"key":"2025092100145609000_104.1.37.24","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90451-P"},{"key":"2025092100145609000_104.1.37.25","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90311-C"},{"key":"2025092100145609000_104.1.37.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq249"},{"key":"2025092100145609000_104.1.37.27","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.53.2.273"},{"key":"2025092100145609000_104.1.37.28","doi-asserted-by":"crossref","first-page":"I212","DOI":"10.1161\/CIRCULATIONAHA.104.517789","article-title":"Right atrial and ventricular adaptation to chronic right ventricular pressure overload","volume":"112","author":"Gaynor","year":"2005","journal-title":"Circulation"},{"key":"2025092100145609000_104.1.37.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.4.427"},{"key":"2025092100145609000_104.1.37.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2009.01.012"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-311274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:15:03Z","timestamp":1758438903000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-311274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,11]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/heartjnl-2017-311274"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-311274","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}